Purolite, an Ecolab company, opened a pharmaceutical manufacturing facility in King of Prussia, Pa. The 74,000 ft2 plant, which includes an expected 75 new jobs, will produce ion exchange resins for healthcare development and pharmaceutical APIs to meet growing demand for existing and future applications and therapies.

The new plant, the company’s fifth manufacturing facility globally, is near Purolite’s headquarters. The facility has two cleanrooms to manufacture active pharmaceutical ingredients (APIs), which will increase the company’s production of APIs by 67 percent.

“This expansion adds to Purolite’s multi-continent ion exchange production to further ensure the security of supply globally and demonstrates our commitment to supporting growing global demand for new healthcare applications and future drug development,” said Gergely Sved, executive vice president and president of Global Healthcare & Life Sciences.